Add to Hoffman’s list, 3 months between getting JAMA approval and publishing our trial results. I think they were waiting on manufacturing and perhaps to get closer to RA approvals. Maybe also waiting for FDA guidelines on tissue agnostic drug? I hope we get JV or partnership soon. Maybe buyout. That’s about the only thing that would cause the company to be so quiet with so much good news to talk about, IMO.
We act like the the C share launch should be ignored. The increase is 500 million shares. That is alot! The only things LP has proven to be consistently good at is dilution and gladly accepting additional equity as bonuses.
They need to hand this off by either buyout or JV/partnership. If given the opportunity I am convinced LP will drag this out another 24+ months